BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9178470)

  • 21. Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors.
    Pontarollo RA; Babiuk LA; Hecker R; van Drunen Littel-van den Hurk S
    J Gen Virol; 2002 Dec; 83(Pt 12):2973-2981. PubMed ID: 12466473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1.
    Zakhartchouk AN; Pyne C; Mutwiri GK; Papp Z; Baca-Estrada ME; Griebel P; Babiuk LA; Tikoo SK
    J Gen Virol; 1999 May; 80 ( Pt 5)():1263-1269. PubMed ID: 10355773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154.
    Manoj S; Griebel PJ; Babiuk LA; van Drunen Littel-van den Hurk S
    Immunology; 2004 Jun; 112(2):328-38. PubMed ID: 15147576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping a highly conserved linear neutralizing epitope at the N-terminus of the gD glycoprotein of bovine herpesvirus type I using a monoclonal antibody.
    Ni H; Jia XX; Wang J; Ran X; Wen X
    Microb Pathog; 2020 Jan; 138():103815. PubMed ID: 31654778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of a bovine herpesvirus-1 (BHV-1) glycoprotein gL which is required for proper antigenicity, processing, and transport of BHV-1 glycoprotein gH.
    Khattar SK; van Drunen Littel-van den Harke S; Attah-Poku SK; Babiuk LA; Tikoo SK
    Virology; 1996 May; 219(1):66-76. PubMed ID: 8623555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polynucleotide vaccines in animals: enhancing and modulating responses.
    Lewis PJ; Cox GJ; van Drunen Littel-van den Hurk S; Babiuk LA
    Vaccine; 1997 Jun; 15(8):861-4. PubMed ID: 9234534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization against bovine herpesvirus-1 infection. Preliminary tests in calves with a DNA vaccine.
    Castrucci G; Ferrari M; Marchini C; Salvatori D; Provinciali M; Tosini A; Petrini S; Sardonini Q; Lo Dico M; Frigeri F; Amici A
    Comp Immunol Microbiol Infect Dis; 2004 May; 27(3):171-9. PubMed ID: 15001312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective immunity in cattle following vaccination with conventional and marker bovine herpesvirus-1 (BHV1) vaccines.
    van Drunen Littel-van den Hurk S; Tikoo SK; van den Hurk JV; Babiuk LA; Van Donkersgoed J
    Vaccine; 1997 Jan; 15(1):36-44. PubMed ID: 9041664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of humoral responses to BHV-1 glycoprotein D expressed by HSV-1 amplicon vectors.
    Blanc AM; Berois MB; Tomé LM; Epstein AL; Arbiza JR
    J Vet Sci; 2012 Mar; 13(1):59-65. PubMed ID: 22437537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope specificity and protective efficacy of the bovine immune response to bovine herpesvirus-1 glycoprotein vaccines.
    Israel BA; Marshall RL; Letchworth GJ
    Vaccine; 1988 Aug; 6(4):349-56. PubMed ID: 2461006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV.
    Taylor G; Rijsewijk FA; Thomas LH; Wyld SG; Gaddum RM; Cook RS; Morrison WI; Hensen E; van Oirschot JT; Keil G
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1759-67. PubMed ID: 9680140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD.
    Zakhartchouk AN; Reddy PS; Baxi M; Baca-Estrada ME; Mehtali M; Babiuk LA; Tikoo SK
    Virology; 1998 Oct; 250(1):220-9. PubMed ID: 9770436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine.
    Belknap EB; Walters LM; Kelling C; Ayers VK; Norris J; McMillen J; Hayhow C; Cochran M; Reddy DN; Wright J; Collins JK
    Vaccine; 1999 May; 17(18):2297-305. PubMed ID: 10403598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intercellular trafficking of the major tegument protein VP22 of bovine herpesvirus-1 and its application to improve a DNA vaccine.
    Zheng CF; Brownlie R; Huang DY; Babiuk LA; van Drunen Littel-van den Hurk S
    Arch Virol; 2006 May; 151(5):985-93. PubMed ID: 16374718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bovine herpesvirus 1-induced apoptotic cell death: role of glycoprotein D.
    Hanon E; Keil G; van Drunen Littel-van den Hurk S; Griebel P; Vanderplasschen A; Rijsewijk FA; Babiuk L; Pastoret PP
    Virology; 1999 Apr; 257(1):191-7. PubMed ID: 10208932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.
    Lewis PJ; van Drunen Littel-van den Hurk ; Babiuk LA
    J Virol; 1999 Dec; 73(12):10214-23. PubMed ID: 10559338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heat shock protein-peptide complexes elicit cytotoxic T-lymphocyte and antibody responses specific for bovine herpesvirus 1.
    Navaratnam M; Deshpande MS; Hariharan MJ; Zatechka DS; Srikumaran S
    Vaccine; 2001 Jan; 19(11-12):1425-34. PubMed ID: 11163665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine mapping of bovine herpesvirus 1 (BHV-1) glycoprotein C neutralizing epitopes by type-specific monoclonal antibodies and synthetic peptides.
    Chowdhury SI
    Vet Microbiol; 1997 Nov; 58(2-4):309-14. PubMed ID: 9453139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins.
    Babiuk LA; L'Italien J; van Drunen Littel-van den Hurk S; Zamb T; Lawman JP; Hughes G; Gifford GA
    Virology; 1987 Jul; 159(1):57-66. PubMed ID: 3037783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.